Hudson Bay Capital Management
RXIIW

Hudson Bay Capital Management’s RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 RXIIW Stock Holding History

Hudson Bay Capital Management’s Portfolio RXIIW Stock Details RXIIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-84,628
Closed -$14K – 591
2017
Q3 		$14K Sell
84,628
-164,557
-66% -$31.7K ﹤0.01% 357
2017
Q2 		$45K Sell
249,185
-532,132
-68% -$104K ﹤0.01% 495
2017
Q1 		$172K Sell
781,317
-1,346,344
-63% -$238K ﹤0.01% 757
2016
Q4 		$404K Buy
+2,127,661
New +$383K 0.01% 551

Other funds holding RXIIW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Hudson Bay Capital Management's RXIIW Position: Q4 2017 in Review

Hudson Bay Capital Management sold out of RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 (RXIIW) in Q4 2017, closing a stake of 84,628 shares — an estimated $14K sold.

Hudson Bay Capital Management first reported a position in RXIIW in Q4 2016 and held it in 4 quarters. The position peaked at $404K in Q4 2016. 4 funds tracked by Wall St. Rank hold RXIIW as of Q4 2017.

  • Hudson Bay Capital Management reported no remaining RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position as of Q4 2017 after selling out during the quarter.
  • Hudson Bay Capital Management sold 84,628 RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 shares in Q4 2017, an estimated $14K.
  • Hudson Bay Capital Management first reported a position in RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 in Q4 2016 and held it in 4 quarters.
  • Hudson Bay Capital Management's RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 position peaked at $404K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held RXi Pharmaceuticals Corporation Warrants expiring 12/16/2021 as of Q4 2017.

Based on Hudson Bay Capital Management's 13F filing for Q4 2017, filed 12 Feb 2018.